The US Food and Drug Administration (FDA) has cleared Medspira's portable mcompass anorectal manometry device.
mcompass is designed to evaluate pelvic floor function in patients with constipation or fecal incontinence.
mcompass incorporates three components including a disposable catheter which is comprised of a central rectal balloon and four radial anal canal balloons at 90 degree relative positioning.
The device’s anal canal balloon is 20 mm long, enabling one or two positioned full anal canal measurements, while a non-compliant rectal balloon supports true rectal compliance testing.
Other components include a wireless portable manometer and mobile tablet PC which display results in real time on the device’s tablet PC workstation.